<DOC>
	<DOCNO>NCT01160471</DOCNO>
	<brief_summary>Background : - Heart failure common cardiovascular disorder whose incidence increase age , affect 10 % people older 65 year age . As population age , prevalence cost heart failure continue rise . Researchers interested use noninvasive imaging method well understand symptom effect heart failure . Objectives : - To conduct noninvasive comparative imaging study individual heart failure . Eligibility : - Individuals least 18 year age diagnose heart failure ( least mild symptom slight limitation physical activity ) . Design : - This study last approximately 2 year require four visit National Institutes Health Clinical Center , one screening visit three study visit . - Participants screen full medical history physical examination , well blood urine sample . - Participants follow test study visit : - Physical examination - Blood urine sample - Cardiac magnetic resonance image - Cardiac computerized tomography study blood vessel lead heart - Echocardiogram evaluate heart function - Electrocardiogram measure heart electrical activity - The three study visit take place 1 year apart . Participants also receive follow-up phone call 6 month first second visit . - No treatment provide part protocol .</brief_summary>
	<brief_title>Noninvasive Imaging Heart Failure : A Pilot Study</brief_title>
	<detailed_description>More 9 % American men close 5 % woman age 60 79 year report diagnosis heart failure , age 80 year figure increase 13.8 % 12.2 % , respectively . Projection middle part century suggest , population age , prevalence cost heart failure continue rise . The primary aim proposal investigate noninvasive imaging method quantify diffuse myocardial fibrosis cardiac magnetic resonance imaging ( CMR ) heart failure patient . The secondary aim investigate association diffuse fibrosis detect CMR leave ventricular function , examine utility multi-detector CT ( MDCT ) detect diffusion myocardial fibrosis .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>INCLUSION CRITERIA : The common inclusion criterion patient control : A . Able understand sign inform consent . B . Able complete MRI CT scan . C. Age great equal 18 year old . Heart Failure subject : D. Men woman clinical diagnosis heart failure . E. New York Heart Association functional class II worse . F. For normal ejection fraction arm . 1 . Preserved leave ventricular ejection fraction ( EF &gt; 50 % ) 2 . Diastolic dysfunction define one follow 1 . LVEDP &gt; 16 mm Hg 2 . PCW &gt; 12 mm Hg 3 . E/E ratio &gt; 15 4 . E/E ratio &gt; 8 AND NTproBNP &gt; 220 pg/mL For systolic dysfunction arm : 3 . Left ventricular ejection fraction &lt; 40 % Normal Control : G. Men woman without clinical diagnosis heart failure . H. NIH employee may involve NIH requirement follow laid NIH Policy Manual 23006303 Leave Policy For NIH Employees Participating In NIH Medical Research Studies . EXCLUSION CRITERIA : Individuals exclude study discover coexistent condition may contribute structural functional cardiac abnormality , may confound interpretation result , ineligible MRI increase risk Nephrogenic Systemic Fibrosis ( NSF ) include : A. Contra indication gadioliniumbased contrast agent : 1. eGFR &lt; 30ml/min/1.73m ( 2 ) 2 . Acute renal failure , renal transplantation , current dialysis treatment hepatorenal syndrome 3 . History liver transplantation severe liver disease 4 . Severe Asthma 5 . Hemoglobinopathies , sickle cell anemia thalassemia major 6 . History multiple myeloma 7 . History significant allergic reaction gadoliniumbased contrast agent B. Coronary artery disease unstable symptom acute coronary syndrome within last six month . C. Medical condition associate increase collagen turnover may confound interpretation biomarkers collagen synthesis . Examples include systemic amyloid disease , cirrhosis , liver , pulmonary , renal fibrosis , inflammatory state , cancer , recent trauma surgery ; D. Pregnant lactate woman ; E. Mental , neurologic social condition prevent understanding rationale , procedure , risk potential benefit associate trial ; F. Any condition precludes safety MRI MDCT per researcher evaluation . G. Patients otherwise eligible follow contraindication iodinebased CT contrast agent exclude contrast CT angiography may undergo study procedure : 1 . Renal dysfunction ( define eGFR &lt; 45 mL/min/m ( 2 ) ) 2 . Current clinical diagnosis renal failure 3 . Prior hypersensitivity iodine contain substance ( shellfish , iodine , previous contrast reaction contrast agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 28, 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Computed Tomography</keyword>
	<keyword>Ultrasound</keyword>
	<keyword>Fibrosis</keyword>
	<keyword>Biomarker</keyword>
</DOC>